Receptor Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are a large family of single-pass cell surface receptors whose cytoplasmic domains catalyze the transfer of phosphate to tyrosine residues. Ligand binding activates the kinase, and the resulting phosphotyrosines act as a recruitment code for downstream signaling proteins, making RTKs central transducers of growth, differentiation, and metabolic signals.

Definition

A receptor tyrosine kinase is a transmembrane receptor with an intrinsic protein-tyrosine kinase domain that, upon ligand binding, autophosphorylates and phosphorylates substrates on tyrosine, thereby initiating intracellular signaling.

Scope

The entry covers the shared architecture of RTKs (extracellular ligand-binding region, single transmembrane helix, intracellular kinase domain), the mechanism of ligand-induced activation and trans-autophosphorylation, the phosphotyrosine-based recruitment of effectors, and the principal downstream cascades. It is a biochemical reference topic and offers no clinical recommendations.

Core questions

• What structural features define the receptor tyrosine kinase family?
• How does ligand binding switch the kinase from inactive to active?
• How do autophosphorylation sites encode the recruitment of downstream proteins?
• Which signaling cascades do RTKs activate and how are they switched off?

Key concepts

• Single-pass transmembrane architecture
• Intrinsic tyrosine kinase domain
• Ligand-induced dimerization
• Trans-autophosphorylation
• Phosphotyrosine docking sites
• SH2 and PTB domain effectors
• RAS-MAPK and PI3K-AKT cascades
• Receptor downregulation by endocytosis

Key theories

Trans-autophosphorylation upon dimerization

Ligand-induced dimerization or oligomerization brings two kinase domains together so each phosphorylates the other, relieving autoinhibition of the activation loop and generating phosphotyrosine docking sites that nucleate downstream signaling.

Mechanisms

An RTK consists of an extracellular ligand-binding region, a single membrane-spanning helix, and a cytoplasmic tyrosine kinase domain. In the resting state the kinase is held inactive by autoinhibitory interactions, often involving the activation loop. Ligand binding promotes receptor dimerization (or reorganizes a preformed dimer), positioning the two kinase domains so they trans-phosphorylate one another; phosphorylation of the activation loop stabilizes the active conformation, and additional autophosphorylation on juxtamembrane and C-terminal tyrosines creates docking sites. Proteins bearing SH2 or PTB domains — adaptors such as GRB2 and enzymes such as PI3K and PLCγ — bind these phosphotyrosines and propagate the signal through the RAS-MAPK and PI3K-AKT cascades. Signaling is terminated by tyrosine phosphatases and by ligand-induced endocytosis and degradation of the receptor.

Clinical relevance

Constitutive RTK activation — through gene amplification, mutation, or fusion — is a recurrent driver in many cancers, and RTKs are the target of numerous kinase inhibitors and antibodies. This entry describes the biochemistry of the receptor family and is not a basis for diagnosis or treatment.

History

RTKs were defined molecularly in the 1980s when cloning revealed that the epidermal growth factor receptor and related growth factor receptors carry intrinsic tyrosine kinase activity homologous to the products of certain oncogenes. The 1990 synthesis by Ullrich and Schlessinger framed the activation logic, and subsequent structural and biochemical work clarified how dimerization, autoinhibition relief, and phosphotyrosine docking convert binding into signaling.

Key figures

• Axel Ullrich
• Joseph Schlessinger
• Mark Lemmon
• Stevan Hubbard

Seminal works

• ullrich-1990
• lemmon-2010
• hubbard-2000

Frequently asked questions

What does the receptor's kinase domain actually phosphorylate?

It transfers phosphate to tyrosine residues — both on the receptor itself (autophosphorylation) and on downstream substrate proteins — and the resulting phosphotyrosines serve as binding sites that recruit signaling proteins.

Why does dimerization activate the kinase?

Pairing two kinase domains allows each to phosphorylate the other in trans, which relieves the autoinhibition that keeps the isolated kinase off and locks it into the active conformation.